Menu

Blog

Archive for the ‘genetics’ category: Page 98

Mar 7, 2023

Scientists explain how an infection can produce genetic diversity

Posted by in categories: biological, genetics, neuroscience

As COVID has demonstrated, when pathogens are moving through the population, we adjust, limiting interactions, even isolating, and generally changing the way we associate with one other. Humans are not alone. New research from Harvard scientists provides some insight into how pathogens change animal social behaviors.

“Extreme environmental conditions have a very strong influence on all animals,” said Yun Zhang, a professor in the Department of Organismic and Evolutionary Biology. But while this behavior has been seen in animals from simple fruit flies all the way up to primates, researchers have not understood what happens inside an individual animal’s brain that leads to infection-induced changes in .

In their new paper, published in Nature, Zhang and colleagues studied the small roundworm C. elegans, which exists in nature with two sexes: hermaphrodites that produce both eggs and sperm, and males. Under normal conditions, the hermaphrodites are loners, preferring to self-reproduce over mating with males. However, Zhang’s team found that the hermaphrodite worms infected by a pathogenic strain of the bacterium Pseudomonas aeruginosa became more interested in one another and increased their mating with males.

Mar 6, 2023

Anti-aging Supplements: Science, Snake Oil, and How Do We Know?

Posted by in categories: bioengineering, biotech/medical, genetics, life extension, science

🇬🇧FREE WEBINAR🇮🇹: https://draronica.com/free-webinar/

In this Ask Me Anything interview, Prof. Matt Kaeberlein discusses the evidence (and lack thereof) behind popular anti-aging supplements and interventions. Starting from his current research on rapamycin for healthy longevity in dogs (The Dog Aging Project), he describes the promises and perils of anti-aging medicine and shares with us some tips on how to become better critical thinkers and protect us from hype and snake oil.

Continue reading “Anti-aging Supplements: Science, Snake Oil, and How Do We Know?” »

Mar 6, 2023

Dr. Felicia Goodrum, Ph.D. — Rational Virology Research For Human Health And Pandemic Prevention

Posted by in categories: biological, biotech/medical, genetics, health

Rational Virology Research For Human Health & Pandemic Prevention — Dr. Felicia Goodrum Sterling, Ph.D. Professor, Department of Immunobiology, The University of Arizona.


Dr. Felicia Goodrum, Ph.D. (https://profiles.arizona.edu/person/fgoodrum) is Interim Associate Department Head and Professor of Immunobiology, as well as Professor, BIO5 Institute, Cellular and Molecular Medicine, Molecular and Cellular Biology, Cancer Biology And Genetics Graduate Interdisciplinary Programs, at the University of Arizona.

Continue reading “Dr. Felicia Goodrum, Ph.D. — Rational Virology Research For Human Health And Pandemic Prevention” »

Mar 6, 2023

Exercise Timing Is Associated With All-Cause Mortality Risk

Posted by in categories: biotech/medical, genetics, health

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Exercise Timing Is Associated With All-Cause Mortality Risk” »

Mar 5, 2023

Review highlights the effectiveness of diet-based low-density lipoprotein lowering over medication

Posted by in categories: biotech/medical, genetics

In a recent article published in the journal Nutrition, researchers in Australia summarized how diet could help decrease low-density lipoprotein cholesterol (LDLc) or triglyceride concentrations in polygenic hypercholesterolemia.

Study: A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology. Image Credit: Ralwell / Shutterstock.

Elevated LDLc or dyslipidemia, including high levels of total cholesterol, increases the risk of cardiometabolic disorders and cardiovascular diseases (CVDs), especially ischemic heart disease (IHD), if not managed in time. Pharmacological treatment is sometimes a prerequisite for cases with complex dyslipidemia with a genetic component. Subsequently, pharmacological research yielded several highly effective drugs based on monoclonal antibody (mAb) therapy, some of which researchers even reviewed in this paper.

Mar 5, 2023

NAD Test #2: Impact of NMN?

Posted by in categories: biotech/medical, genetics

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “NAD Test #2: Impact of NMN?” »

Mar 4, 2023

Determining the tempo of evolution across species

Posted by in categories: biotech/medical, evolution, genetics

Scientists from Denmark and China have estimated germline mutation rates across vertebrates by sequencing and comparing genetic samples from 151 mother, father, and offspring trios from 68 species of mammals, fishes, birds and reptiles. A bioinformatics pipeline was designed to read, analyze and compare the genome mutations that occur yearly and between generations in each species.

The research was published March 1, 2023, in the journal Nature.

Knowing the germline mutation rate could allow a greater understanding of evolutionary drivers and be used to estimate when a species first arose. Despite the variety of evolutionary paths seen in 68 different species, researchers found the germline mutation rate to be relatively conserved.

Mar 4, 2023

George Church: Biomanufacturing, CRISPR,1 million cell edits, Woolly mammoth-Learning with Lowell-164

Posted by in categories: engineering, genetics, life extension

George Church is a geneticist known for his pioneering work in developing new technologies for genome sequencing, editing, and synthesis. He has also been involved in research on genome engineering and gene therapy.

Links.
https://wyss.harvard.edu/team/core-faculty/george-church/
https://arep.med.harvard.edu/

Continue reading “George Church: Biomanufacturing, CRISPR,1 million cell edits, Woolly mammoth-Learning with Lowell-164” »

Mar 4, 2023

Chroma Scores $135M for Epigenetic Editing Approach

Posted by in categories: biotech/medical, genetics

Backed by Google Ventures, ARCH Venture Partners and more, Chroma Medicine announced the closing of a $135 million Series B financing Wednesday.

Mar 3, 2023

Reversed With a Single Drug — “Incurable” Liver Disease May Be Curable

Posted by in categories: biotech/medical, genetics

A new study from Sanford Burnham Prebys has discovered a drug that can spur liver regeneration in patients with Alagille syndrome.

For the first time, research conducted by Associate Professor Duc Dong, Ph.D. has revealed that the detrimental effects of Alagille syndrome, a genetic disorder that has no cure, can be reversed using a single drug. The findings, published in the Proceedings of the National Academy of Sciences, have the potential to revolutionize the treatment approach for this rare condition, and could also shed light on more widespread diseases.

“Alagille syndrome is widely considered an incurable disease, but we believe we’re on the way to changing that,” says Dong, who is also the associate dean of admissions for Sanford Burnham Prebys’ graduate school. “We aim to advance this drug into clinical trials, and our results demonstrate its effectiveness for the first time.”